Business Standard

Natco Pharma gets environmental nod for API plant expansion in Telangana

Project is expected to employ 1,200 persons directly and 300 persons indirectly after the expansion

An extra dose of tax on medicines
Premium

BS Reporter Chennai
Hyderabad-based Natco Pharma is expected to expand its active pharmaceutical ingredients (APIs) and API Intermediates manufacturing facility in Telangana's Rangareddy district, with a total estimated project cost of Rs 480.31 crore. The project has recently received environmental clearance from the Union government.

According to the approval by the Union Ministry of Environment, Forest and Climate Change, the expansion will be taking place in the existing land area, with an estimated project cost of Rs 480.31 crore, including existing investment of around Rs 314.31 crore.

It added that the facility has been manufacturing three products and the proposal is to build capacities for

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in